GRT.JO
Growthpoint Properties Limited
$1,684.00
+35.00
(+2.12%)
Mkt Cap
57.05B
Volume
5,273,897
52W Range
1285-1892
Sector
Real Estate
Beta
0.63
EPS (TTM)
1.61
P/E Ratio
1045.96
Revenue (TTM)
13.57B
Rev Growth (5Y)
+1.9%
EPS Growth (5Y)
-1.8%
Company Description
Growthpoint is the largest South African primary JSE-listed REIT with a quality portfolio of 440 directly owned properties in South Africa (RSA) valued at R73.4bn, including four hospitals and one medical chambers valued at R2.6bn owned by Growthpoint Healthcare Property Holdings (RF) Limited (GHPH). Growthpoint has a 61.8% shareholding in GHPH. We have a 62.2% interest in ASX-listed Growthpoint Properties Australia Limited (GOZ), which owns 58 properties in Australia valued at R51.8bn and a 52.1% interest in LSE-listed Capital & Regional Plc (C&R), which owns seven properties in the United Kingdom valued at R14.8bn.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 13.57B | 14.40B | 13.74B | 13.05B | 13.13B | 12.36B | 11.55B | 10.93B | 10.76B | 10.22B | 7.87B | 6.61B |
| Net Income | 5.46B | 1.27B | 2.36B | 7.94B | (497.00M) | (6.87B) | 6.32B | 6.66B | 7.52B | 5.16B | 6.96B | 5.58B |
| EPS | 1.61 | 0.37 | 0.69 | 2.33 | -0.15 | -2.30 | 2.14 | 2.29 | 2.68 | 1.90 | 2.95 | 2.79 |
| Free Cash Flow | 696.00M | 5.67B | 7.21B | 5.76B | 4.83B | 5.53B | 6.44B | 6.75B | (612.00M) | 649.00M | N/A | N/A |
| FCF / Share | 0.21 | 1.68 | 2.12 | 1.69 | 1.49 | 1.85 | 2.18 | 2.32 | -0.22 | 0.24 | N/A | N/A |
| Operating CF | 746.00M | 5.74B | 7.26B | 5.80B | 4.88B | 5.56B | 6.46B | 6.76B | (603.00M) | 652.00M | N/A | N/A |
| Total Assets | 152.18B | 165.74B | 171.98B | 164.73B | 154.46B | 168.50B | 141.78B | 137.36B | 126.86B | 118.53B | N/A | N/A |
| Total Debt | 63.09B | 72.25B | 70.28B | 64.68B | 64.18B | 73.71B | 51.62B | 48.23B | 42.57B | 34.09B | N/A | N/A |
| Cash & Equiv | 1.81B | 1.91B | 3.36B | 2.84B | 2.62B | 2.42B | 882.00M | 2.32B | 613.00M | 862.00M | N/A | N/A |
| Book Value | 67.33B | 68.27B | 71.91B | 71.21B | 66.41B | 67.88B | 74.91B | 75.27B | 72.05B | 68.30B | N/A | N/A |
| Return on Equity | 0.08 | 0.02 | 0.03 | 0.11 | -0.01 | -0.10 | 0.08 | 0.09 | 0.10 | 0.08 | N/A | N/A |
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 | Q4 2020 | Q2 2020 | Q4 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6.77B | 6.65B | 6.92B | 7.28B | 7.12B | 6.89B | 6.85B | 6.67B | 6.38B | 6.43B | 6.70B | 6.64B |
| Net Income | 2.41B | 2.76B | 2.51B | 1.11B | 157.00M | 490.00M | 1.87B | 4.29B | 3.65B | 810.00M | (1.31B) | (10.24B) |
| EPS | 0.71 | 0.81 | 0.74 | 0.33 | 0.05 | 0.14 | 0.55 | 1.26 | 1.07 | 0.24 | -0.42 | -3.42 |
| Free Cash Flow | 2.89B | 2.93B | 2.77B | 3.33B | 2.34B | 3.28B | 3.93B | 2.47B | 3.29B | 959.00M | 3.87B | 1.67B |
| FCF / Share | 0.85 | 0.86 | 0.82 | 0.98 | 0.69 | 0.97 | 1.15 | 0.73 | 0.97 | 0.28 | 1.25 | 0.56 |
| Operating CF | 2.91B | 2.94B | 2.79B | 3.36B | 2.38B | 3.29B | 3.97B | 2.50B | 3.30B | 985.00M | 3.89B | 1.69B |
| Total Assets | 154.10B | 152.18B | 152.94B | 165.74B | 169.31B | 171.98B | 168.17B | 164.73B | 168.18B | 154.46B | 158.60B | 168.50B |
| Total Debt | 64.50B | 63.09B | 64.37B | 72.25B | 71.70B | 70.28B | 67.69B | 64.68B | 64.97B | 64.18B | 65.42B | 73.71B |
| Cash & Equiv | 1.81B | 1.81B | 1.67B | 1.80B | 2.66B | 3.36B | 3.35B | 2.84B | 2.23B | 2.62B | 3.16B | 2.42B |
| Book Value | 66.93B | 67.33B | 66.76B | 68.27B | 69.62B | 71.91B | 71.75B | 71.21B | 69.80B | 66.41B | 68.30B | 67.88B |
| Return on Equity | 0.04 | 0.04 | 0.04 | 0.02 | 0.00 | 0.01 | 0.03 | 0.06 | 0.05 | 0.01 | -0.02 | -0.15 |
GRT.JO News
No news available for GRT.JO.